It is reported that arsenic reduces the invasive and metastatic properties of glioma tumor cells via inhibition of activation of matrix metalloproteinase-14 (MT1-MMP) [7], [25], which is able to drive invasion of cancer cells largely by degrading ECM barriers. Here, MMP14 is linked to central nervous system cancer.